BioLattice Ophthalmics, Inc,

BiotechnologyBiotechnologyOphthalmics

📍 Philadelphia, PA, USA

StreetZero Signal 73

Be the first to signal interest

About BioLattice Ophthalmics, Inc,

BioLattice Ophthalmics, Inc. is a biotechnology company focused on ophthalmics. It is headquartered in Philadelphia, PA. The company completed a $1.825 million private placement.

LATEST FUNDINGPrivate Placement

$1.8M

Announced 2026-10-28

TOTAL RAISED$1,825,000

🔒

Unlock the full deal profile

Create a free account to see investors, key highlights, news, company details and the AI analysis for BioLattice Ophthalmics, Inc,.

Create free account Sign in

Free plan includes 3 full deal profiles every month.

EMPLOYEES—

FOUNDED—

HQPhiladelphia, PA, USA

Industry

Biotechnology

Investors

Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.

Key highlights

Completed a $1,825,000 private placement.
Based in Philadelphia, PA.
Operates in the biotechnology sector.
No investor names disclosed.

Ask StreetZero about BioLattice Ophthalmics, Inc,

Put our AI to work on this deal.

What is BioLattice Ophthalmics, Inc,'s value proposition?Who are BioLattice Ophthalmics, Inc,'s competitors?Why does this raise matter?Summarize BioLattice Ophthalmics, Inc, for an investor.

Similar companies

Other Biotechnology deals, ranked by Signal.

Elucid Bioimaging Inc.

$56.2M

BigHat Biosciences, Inc.

$75.1M

Nuclein, LLC

$15.7M

Allyx Therapeutics, Inc.

$27.9M

Source document & SEC filing

The source SEC filing and the cached document are available to members only. Sign in to view and download them.